NextGen Biomed 2027
.svg)
18 - 19 March 2027
InterContinental London, UK
InterContinental London, UK
.png "ngb onsite (1)")
.png "ngb onsite (2)")
.png "ngb onsite (3)")
.png "ngb onsite (4)")
Alexander Eggermont
Professor Immunotherapy of Cancer,
University Medical Center Utrecht
Anders Gabrielsen
Vice President & Head of Global Clinical Development,
Ribocure
Andrew Feilden
Senior Director Analytical Science,
Bicycle Therapeutics
Anna Perdrix
co-CEO,
Sixfold Bioscience
Brian Schanen
Head of Biomarker Research for the mRNA Center of Excellence,
Sanofi
Chris Herring
Vice President of Biology & Safety,
T-Therapeutics
Daniel Fleischanderl
Director Upstream Development,
Boehringer Ingelheim
Daniel Larocque
Innovation Leader,
Sanofi
Fernando Albericio
Research Professor,
University of KwaZulu-Natal
Hannah Bolt
Head of Peptide Discovery, Director,
AstraZeneca
Joanna Calvert
Senior Programme Manager - UK Vaccine Innovation Pathway,
NIHR
Karen Silence
Vice President, Head of Preclinical Product Development ,
Argenx
Lilly Wollman
Co-Founder & Chief Executive Officer,
Synteny
Livija Deban
Chief Scientific Officer,
Prokarium
Marion Fresch
Senior Scientist QC,
Bachem
May Sabry
Senior Director, Precision Medicine,
AstraZeneca
Morten Meldal
Professor, Department of Chemistry,
Københavns Universitet
-9b7986.jpg?length=600&name=629f5fda-8b3e-4217-8166-757bcc6e37be-2-11764368speaker_photo-Paul-Kellam-(1)-9b7986.jpg)
Paul Kellam
Chief Scientific Officer,
RQ Biotechnology
Prasun Chakraborty
CEO and Founder,
Genevation LTD
Simon Plyte
CSO,
Biomunex Pharmaceuticals
Agnieszka Lewandowska
Associate Director Analytical Development,
Immunocore
Aidan Riley
Associate Director,
AstraZeneca
Alessandra Tolomelli
Professor,
University of Bologna
Alexander Davydov
Community Contribution Lead,
OHDSI
Alexandra Sevko
Vice President, Translational Science,
Amphista
-dc0648.jpg?length=600&name=e77ff5c9-1ce6-46f4-b4af-398b52b3c047-2-11764368speaker_photo-Ali-Roghanian-CCI-(2)-dc0648.jpg)
Ali Roghanian
Associate Professor in Cancer Immunotherapy,
University of Southampton
Allan Bradley
CSO,
T-Therapeutics
Alsya Affandi
Lead Scientist,
Amsterdam UMC, Immunara Tx
Amberley Stephens
Associate Principal Scientist,
AstraZeneca
Amjad Khan
Former Global Digital Client Partner for Vaccines,Hospital and Medical Affairs,
Pfizer Ltd
Anders Dahlén
Senior Director,
AstraZeneca
Andreas Hollenstein
Senior Principal Scientist,
Roche
Andreas Plueckthun
Professor Of Biochemistry, Director, Department Of Biochemistry,
University of Zurich
Andrew Henry
Principal Scientist,
Chemical Computing Group
Angus Sinclair
Chief Scientific Officer,
LabGenius Therapeutics
Anis Gammage
Principal (Head of Scoping),
Deep Science Ventures
Annabelle Herrington-Symes, PhD
Biologics Discovery & Development Senior Scientist,
LifeArc
Antima Gupta
Senior Application Scientist,
Collaborative Drug Discovery
Apolline Lefevre
Clinical Pharmacology Sciences & Analytics,
Roche
Barbara Ciani
Senior Lecturer,
University of Sheffield
Beth Wensley
Principal Scientist - Protein and Analytical Sciences,
LifeArc
Birgit Piater
Associate Scientific Director, ADC Biology,
Merck KGaA
Blake Mazzitelli
Senior Scientist II,
Maxion Therapeutics
Brenda Iglesias
Associate Director, Strategic Partnerships,
GSK
Brian Weinert
Principal Scientist & Discovery Project Lead,
Nykode Therapeutics
Callum Scott
Head of Development,
Scancell Ltd
Campbell Stewart
Principal,
Novo Holdings
Catherine Stace
Executive Vice President,
Kuano
Cécile Brocard
Head of Downstream Development,
Boehringer Ingelheim
Cerlin Roberts
Founder & Chief Executive Officer,
Oxford Global
Charles Johannes
Co-Founder & President,
FogPharma
Charlotte Deane
Professor,
Centre for Medicines Discovery
Christian Garde
Director, Bioinformatics,
Evaxion AI
Christian Hunzinger
Senior Director CMC Development Proteins, ADCs. & Clinical Entities,
BioNTech
Christopher Lloyd
Director,
AstraZeneca
Christopher Ullman
Chief Executive Officer,
Stratosvir Ltd
Colby Souders
CSO,
Twist Bioscience
Colette Johnston
VP - Head of Product Platform Research,
Enara Bio
Dan Kristensen
Scientific Director,
Symphogen A/S
Darryl Hayward
Antibody Discovery Scientist,
GSK
David Rodríguez
Associate Director,
Novo Nordisk
Denise Steckel
Head of Clinical Collaborations Development,
Genentech
Dennis Ungan
Principal Scientist,
Novartis
Dimitri Sideris
Senior Scientist,
AstraZeneca
Dorothy Bray
Director,
Celtic Biotech
Ebru Dogruol
Vice President Commercial,
Pfizer
Elaine Dymond
Managing Director,
Dymond Pharma Consultancy Limited
Elisabetta Bianchi
Director of Discovery Chemistry,
Curium Biopharma
Erik Briers
Board Member,
WeCan Foundation & Europa Uomo
Esam Abualrous
Principal Scientist I, Applications Science,
Schrödinger
Fabien Rousset
Director Global Innovation,
PolyPeptide Group
Fabio Centola
CQA Manager,
Merck & Cie KmG
Federico Riccardi Sirtori
Director, Head of NBE-DMPK Innovative Bioanalytics,
Merck & Cie KmG
Felix Wojcik
Principal Scientist,
Novo Nordisk
Florian Bossard
Scientific Sales Manager,
Vixen Bio
Freddie Martin
Senior Scientist I, Applications Science,
Schrödinger
Gokhan Yahioglu
Co-Founder & Director of Chemistry,
Antikor Biopharma
Gry Persson
Senior Project Manger, Infectious Diseases,
evaxion.ai
Gurdaman Singh
Scientific Investigator,
GSK
Hans Melo
Chief Executive Officer,
Menten AI
Hans van der Vliet
Professor, Medical Oncologist,
Amsterdam UMC
Harry Taylor
Senior Project Manager,
Photene
Heinrich Haas
Chief Technology Officer,
Neovacs
Henrik Ihre
Distinguished Fellow, R&D,
Cytiva
Hussein Al-Mossawi
Fellow and Lecturer in Pathology & Immunology,
University of Oxford
Ivan Gladwyn-Ng
Business Development Senior Scientist,
Cyagen
James Legg
Chief Scientific Officer,
Cytospire Therapeutics
Jennifer Mataraza
Executive Director and Head, Translational Immuno-Oncology,
Novartis Institutes For Biomedical Research
Jerome Mastio
In Vivo Associate Principal Scientist,
AstraZeneca
Joel Benjamin Heim
Senior Project Manager,
Nykode Therapeutics
John Bridgeman
Cso,
Immunokey
Joost Uitdehaag
Head of Biology,
Crossfire Oncology B.V.
Justyna Mysliwy
Executive Director of Research,
Iksuda Therapeutics
Kai Hilpert
Professor,
City St George's, University of London
Kamaraj Karunanithi
Director of Research and Innovation,
University Hospitals of North Midlands NHS Trust
Karin Hrovatin
Bioinformatic Scientist,
Merck KGaA
Kate Smith
UK Head Protein And Cell Sciences,
GlaxoSmithKline
Katy Lloyd
Associate Director,
Genmab
Ken Chow
Health Tech Counsel,
Flanders Investment & Trade, Belgium Embassy (London)
Larisa Soldatova
Professor & Reader in Data Science,
University of London
Laura Acqualagna
Director of AI/ML Engineering,
GSK
Lei Shi
Senior Vice President,
Biointron
Louise Brackenbury
Science Director,
Charles River Laboratories
Lukas Leder
Senior Principal Scientist,
Novartis
Mali Eskandarpour
Senior Research Fellow,
University College London
Manuel Vega
Chief Executive Officer,
AGS Therapeutics
Marc Siggel
Senior Scientist,
Merck KGaA
Marc Vendrell
Professor of Translational Chemistry,
University of Edinburgh
Maria Ascierto
Professor Translational Cancer Immunology; Head Scotland CRUK Clinical Biomarkers Hub,
University of Glasgow
Mariolina Salio
Director Experimental Immunology,
Immunocore
Marjolein Van Egmond
Professor in Oncology and Inflammation,
Amsterdam UMC Genome Diagnostics
Mark Austin
Associate Director In vitro Display,
AstraZeneca
Mark Eccleston
CEO,
Valirx
Matthew Burke
Senior Scientist,
UCB
Mattia Cocco
Associate Director,
AstraZeneca
Michael Anyadiegwu
CMC Technology Lead,
CEPI
Michael Delaney
Senior Principal Scientist,
Novo Nordisk
Michelle Barnard
Director of Research,
ValiRx
Miguel Gaspar
Senior Director, Oncology R&D,
Astrazeneca
Mihaela Bozic
Scientist,
T-Therapeutics Ltd
Mikhail Kuravskiy
Principal Scientist,
UCB
Mohammad Arastoo
Research Fellow,
University of Aberdeen
Nathan Alves
Research Director,
Indiana University School of Medicine
Nathaniel Goldberg
R&D Scientist II,
Aralez Bio
Nazim Uddin
Senior Development Scientist,
Scancell
Nehil Chaturvedi
Senior Technical Project Lead,
Leukocare AG
Ni Huang
Associate Director,
T-Therapeutics Ltd
Nicola Bonzanni
Founder and CEO,
ENPICOM
Nicola Burgess-Brown
Professor,
UCL
Obinna Ubah
Principal Scientist & Programme Lead,
Elasmogen
Omar Aziz
Scientific Business Director,
Charles River Laboratories
Paolo Marcatili
Head of Antibody Design,
Novo Nordisk
Peter Molloy
Senior Fellow, Protein Engineering,
Immunocore
Philip Gaskin PhD
Director of Business Development,
The Jackson Laboratory
Poorvaja Ganesan
Scientist III Upstream Process Development,
Alexion Pharmaceuticals, Inc.
Rémi Palmantier
CEO,
ImmThera Consuting SAS
Rhiannon Jenkinson
Chief Scientific Officer,
Nexus Bioquest
Ricardo Carreira
Associate Director,
Immunocore
Rikhav Gala
Group Leader - Senior Principal Scientist,
Pfizer Ltd
Russell LaMontagne
Chief Executive Officer,
BITT
Saif Shubber
Associate Director,
Bicycle Therapeutics
Sara Trabulo
CMC & Analytical Development,
AstraZeneca
Sarah Harris
Professor of Biological and Materials Physics,
University of Sheffield
Sebastian Birkedal
Senior Scientist Downstream Process Development,
Byondis
Sebastian Wolfgang Draxler
Principal Scientist Analytics,
Bayer
Sepideh Afshar
Senior Director,
Genentech
Sergio Martinez Cuesta
Principal Data Scientist,
AstraZeneca
Shashi Jatiani
Director,
SeromYx Systems Inc
Silvia Crescioli
Antibody Therapeutics Pipeline Expert,
Independent Consultant
Simon Brunner
Principal,
Flagship Pioneering
SM Chen
researcher,
Asymchem
Sofie Voet
Principal Scientist,
argenx
Sonia Macia
Chief Medical Officer,
OneChain Therapeutics
Sophia Karagiannis
Professor of Translational Cancer Immunology and Immunotherapy,
King's College London
Sridhar Neelamraju
Associate Principal Informatician,
AstraZeneca
Sritama Bose
Associate Director of Chemistry,
Orfonyx Bio
Steffen Goletz
Professor, Department of Biotechnology and Biomedicine,
Danish Technical University
Stephanie Linker
Senior Computational Biochemist,
Merck & Cie KmG
Stephen Lock
Senior market development manager,
SCIEX
Steve Hood
Senior Director,
GSK
Steven Rust
Head of Protein Biotherapeutics,
Biotech in Stealth
Sudhir Agrawal
President & Founder & Affiliate Professor,
Arnay Sciences
Sue Charlton
Head of Clinical Evaluation,
UK Health Security Agency
Supriyadi Hafiz
Senior Scientist,
Merck
Takashi Ebihara
COO,
GeneFrontier Corporation
Thomas Kofoed
Chief Executive Officer,
Alphalyse
Tiffany Rau
Professor,
University of College Cork & Owner, Bio Pharma Technical Consulting
Tobias Von Der Haar
Professor,
University of Kent & Jantomarna Therapeutics Ltd
Tom Bosschaerts
Chief Operations Officer,
ImmuneWatch
Vaios Karanikas
Biomarker Portfolio Leader,
Roche
Vicky Brentville
Principle Scientist,
Scancell
Victor Goldmacher
Chief Scientific Officer,
Immuvia Therapeutics
Vivek Verma
Lecturer,
Imperial College London
Walter Cabri
Professor,
University of Bologna
Wenhui Song
Professor,
University College London
Xi Zhao
Head, Oncology Bioinformatics, Research & Development,
AbbVie
Xinxin Gao
Senior Principal Scientist,
Genentech
Yashas Kannan
Vice President Drug Discovery,
PentaBind
Yi-Ru Yu
Lead Scientist,
Pilatus Biosciences SA
Yongqun He
Professor,
University of Michigan
Who Sponsored NextGen Biomed 2026?
Gold Sponsors
Ajinomoto Co.,
Gold Sponsor
The Ajinomoto Group is a global company focused on the research, development, and manufacture of high quality products for the pharmaceutical, specialty chemical, nutraceutical, sports nutrition, and health & beauty industries, as well as food seasonings and consumer food products. Headquartered in Tokyo, the Ajinomoto Group has over 34,500 employees, maintaining operations in 36 countries and regions, and possessing a global production network of 117 factories. In fiscal 2023, sales were JPY 1,439 billion (USD 9.1 billion).
Chemical Computing Group
Gold Sponsor
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG provides state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG headquarters are in Montreal (Canada), with support offices in North America, Europe and Asia.
Cradle
Gold Sponsor
Cradle’s mission is to make engineering biology easier, quicker and more cost-effective. Its enterprise-grade AI software platform currently serves 6 out of the top 25 global pharma companies, and is used across over 50 R&D programs. With Cradle, scientists can engineer better proteins, faster and more successfully, speeding up the development cycle of new therapeutics and bio-based products such as, antibodies, enzymes, and bio-based materials.
ENPICOM
Gold Sponsor
ENPICOM is an innovative software engineering company committed to accelerating biologics discovery and development. With a deep understanding of biology, software engineering, and AI, ENPICOM delivers tailored, scalable tools that enable scientists to easily access and apply AI models for decision-making. We help transform complex workflows into efficient scientific outcomes, reducing costs and shortening the path to innovative treatments.
GenScript
Gold Sponsor
Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,500 employees and has served more than 200,000 customers across over 100 countries and regions.
NanoTemper Technologies
Gold Sponsor
At NanoTemper, our vision is to help create a world where every disease is treatable. For us, that starts by equipping scientists with biophysical solutions they trust, helping them solve their toughest challenges and ultimately discover life-saving therapies
That’s why we build our tools with high-quality materials that give scientists clear and reliable results. Made to be easy-to-learn, easy-to-use, and automation-ready, our solutions streamline workflows while increasing efficiency. We support our customers with in-depth knowledge and scientific expertise at every stage of their journey.
Since 2008, research teams at top biotech and pharmaceutical companies, as well as leading research institutions around the world, have used NanoTemper tools to get ahead in their research.
Instrument lines include Monolith for binding affinity measurements in solution, Dianthus for hit-screening, Prometheus for protein stability characterization and Andromeda for protein expression optimization.
If you’re facing challenges with affinity screening, molecular interactions, protein stability, or protein expression, let’s talk.
Schrödinger
Gold Sponsor
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel molecules for drug development. Schrödinger also leverages its platform to advance a portfolio of proprietary and collaborative programs including three proprietary clinical-stage programs. Visit www.schrodinger.com or our blog Extrapolations.com.
SeromYx Systems
Gold Sponsor
SeromYx Systems helps vaccine and antibody therapeutic developers understand how their molecules actually function in the immune system.
We provide high-throughput, primary-cell functional assays and Fc profiling to evaluate effector function, immune engagement, and safety-relevant mechanisms across antibodies, Fc-engineered variants, and vaccines. Our data help teams make better decisions on candidate selection, Fc engineering, and translational risk before IND.
With a GCLP-certified platform and deep expertise in Fc-mediated biology, SeromYx supports programs from early discovery through clinical development.
Thermo Fisher Scientific
Gold Sponsor
ABOUT PATHEON
As a subsidiary of Thermo Fisher Scientific, Patheon strives to provide industry-leading pharma services solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. With more than 55 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including biologics, viral vectors, formulation, clinical trials solutions, logistics services and commercial manufacturing and packaging. We give pharma and biotech companies of all sizes instant access to a global network of facilities and technical experts across the Americas, Europe, Asia and Australia. Our global leadership is built on a reputation for scientific and technical excellence. As a leading pharma services provider, we aim to deliver unrivaled quality, reliability and compliance. Together with our customers, we’re rapidly turning pharmaceutical possibilities into realities.
Silver Sponsors
Ailux
Silver Sponsor
Ailux is a biologics innovation company dedicated to developing advanced biotherapeutics with AI-powered solutions. As XtalPi’s dedicated biologics platform, Ailux integrates proprietary computational models with state-of-the-art wet lab capabilities to tackle previously undruggable targets and design molecules with novel therapeutic profiles. With a global team of more than 100 members, Ailux partners with leading biopharmaceutical companies to translate cutting-edge science into transformative medicines.
Alloy Therapeutics LLC
Silver Sponsor
Alloy Therapeutics is a biotechnology ecosystem company empowering the future of drug discovery and development with AI-powered platforms and scientific expertise. Through a collaborative partnership approach, Alloy provides access to technologies, services, and company-creation capabilities that are foundational to discovering and developing therapeutic biologics across multiple therapeutic modalities: antibodies, bispecifics, TCRs, genetic medicines, cell therapies, and drug delivery.
Alloy integrates AI/ML into its discovery and development infrastructure, combining proprietary models, real-world data, and human expertise to help partners advance therapeutic programs. At Alloy, we are redefining biologics redevelopment by reducing the time and cost to advance programs from discovery to human data. Join the Alloy Therapeutics community by visiting www.alloytx.com and following Alloy on LinkedIn.
Alphalyse
Silver Sponsor
Alphalyse is the world’s leading authority in LC-MS–based HCP analysis, with a singular focus on HCPs. Since 2002 we have been developing and providing GMP-compliant LC-MS/MS services and have developed the largest HCP dataset globally..
In today’s regulatory environment across all biologic manufacturing modalities, Process Development is no longer just about yield; it’s about achieving Total Process Understanding as part of the globally evolving Life-Cycle regulatory approach to drug approval. Regulators and even potential partners assessing your biologic asset are now expecting you know exactly which impurities are present and how they are cleared at every stage of your process. With 75% of the 200+ recent FDA CRLs are linked to CMC inadequacies, our GMP-compliant LC-MS/MS data is an essential tool for your workflow, providing the granular detail needed to optimize purification steps and prove to regulators that you have full control over your product’s impurity profile
AmbioPharm
Silver Sponsor
AmbioPharm is a global peptide CDMO founded in 2005 and headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at clinical and commercial stages. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA as well as other global regulatory bodies with excellent outcomes. Our mission is to accelerate your peptides to patients.
Aralez Bio
Silver Sponsor
Aralez Bio (Berkeley, CA) is expanding the chemical universe with a proprietary enzyme platform that merges unmatched molecular diversity with seamless scale-up. We solve the bottleneck of limited chemical variety in drug discovery by providing access to the world's largest portfolio of novel noncanonical amino acids. Our technology creates a reliable bridge from the lab to the plant, transitioning from milligram discovery to ton-scale production without the typical "scale-up surprise." By delivering unparalleled atomic-level control through a sustainable, single-step process, we help you transform molecules into medicine. Be Noncanonical.
Biointron
Silver Sponsor
Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.
Biointron holds a leading position in the antibody expression service industry. From gene sequence to purified antibodies, our production only takes 2 weeks. We have delivered tens of thousands of recombinant antibodies for more than 2,500 biotech and pharma companies worldwide. Contact us: +1(732)790-8340, or info@biointron.com. Visit our website: www.biointron.com
Charles River Laboratories
Silver Sponsor
At Charles River, we’re dedicated to helping clients accelerate research and drug development—because every moment matters. Our essential products and services empower pharmaceutical, biotech, government, and academic teams to turn possibilities into breakthroughs. From discovery to early development and safe manufacturing, we provide the solutions clients need to bring new therapies to patients faster.
-73f6bb.png?length=600&name=17e93cb8-3eb9-4d48-9b0b-ce8d537ba74f-2-5668375logo-CPCLogo_TidesPartner-(3)-73f6bb.png)
CPC Scientific
Silver Sponsor
Founded in 2001, our group is a globally recognized Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in peptides and oligonucleotides. Our integrated service model is designed to support partners through the most critical phases of drug development, with a particular focus on late-phase development, large-scale manufacturing, and commercial production. From initial discovery to full commercialization, we provide the expertise and infrastructure to accelerate your peptide and oligonucleotide programs to success.
In June 2025, CPC Scientific’s parent company, Medtide Inc., was officially listed on the main board of the Hong Kong Stock Exchange, marking a major milestone that reflects our continued growth and global impact.
Cyagen Bioscience
Silver Sponsor
Founded in 2006, Cyagen is a global provider of genetically modified rodent models and advanced CRO solutions for biomedical research and drug development. With more than 900 employees and multiple research facilities covering 40,000 m², we serve researchers in more than 100 countries and support over 13,000 peer-reviewed publications – including in Cell, Nature, and Science.
Headquartered in Santa Clara, California, Cyagen also operates subsidiaries in Japan and China, along with major R&D and production centers in Guangzhou, Suzhou, and Gu'an (China).
Leveraging its robust foundation in cell and animal model generation alongside powerful AI-driven discovery platforms, Cyagen offers scalable, reliable, and expert-backed one-stop solutions for accelerating both basic research and preclinical drug development.
Cytiva
Silver Sponsor
Cytiva is a global life sciences leader dedicated to helping customers discover and commercialize the next generation of therapeutics. Together, we bring dedicated technical expertise and a broad portfolio of tools and technologies that enable the development, manufacture, and delivery of transformative medicines to patients. Visit cytiva.com to learn more.
NOF Europe GmbH
Silver Sponsor
NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators.
PolyPeptide Laboratories
Silver Sponsor
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical through to commercial stages. Its broad portfolio reflects the opportunities in drug therapies across areas and with a large exposure to metabolic diseases, including GLP-1. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
ProBio
Silver Sponsor
ProBio is a global leader in enabling biotech and pharmaceutical companies to advance the development and manufacturing of next-generation biologics and advanced therapies. As a fully integrated end-to-end Contract Development and Manufacturing Organization (CDMO), ProBio supports its partners in optimizing drug development, accelerating time-to-market, and provides comprehensive life-cycle support.
Through a collaborative and risk-sharing model, ProBio offers flexible options for licensing and co-development of new therapeutics. This enables our partners to effectively navigate the complexities of human disease with adaptable and versatile therapeutic approaches.
To learn more about ProBio services, please visit www.probiocdmo.com
SCIEX
Silver Sponsor
SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all.
Today, as part of the Danaher family of global life science and technology innovators, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis.
That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.
Solvias
Silver Sponsor
Solvias helps innovative companies advance their path to commercialization with CMC analytical solutions powered by deep scientific expertise and a relentless focus on customer success. With extensive experience in small molecules, biologics, and cell and gene therapies, our experts apply creativity and rigor to solve even the most complex analytical challenges. Customers gain a single, trusted partner through our GMP, GLP, and ISO-certified facilities across five global locations, conducting over 100 successful audits each year.
Sunresin New Materials
Silver Sponsor
Sunresin is a global leader in ion exchange and adsorbent resins, providing innovative purification, separation, and extraction solutions for highly regulated industries. With strong expertise in Life Sciences—including chromatography, peptide and oligonucleotide synthesis, catalysis, and APIs—Sunresin delivers advanced technologies for biopharma downstream processing. Operating five ISO-certified automated plants with 70,000 m³ annual capacity and over 1,400 employees worldwide, Sunresin ensures innovation, quality, and supply chain reliability.
Twist Bioscience
Silver Sponsor
At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture and industrial chemicals, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.
Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com.
Unchained Labs
Silver Sponsor
Here’s the deal. We’re all about helping biologics and gene therapy researchers break free from tools that just don’t cut it. Unleashing problem-tackling solutions that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.
Bronze Sponsors
A&M STABTEST
Bronze Sponsor
A&M STABTEST is a Germany-based contract testing organization specializing in characterization and QA analysis of peptides, oligonucleotides, and proteins.
With more than 30 years of experience, we provide stability and release testing, method development and validation, forced degradation studies, and in-use studies (including CSTD compatibility).
We deliver analytical services to the highest quality standards and operate under GMP certification with flaawless FDA inspection history.
ACROBiosystems
Bronze Sponsor
ACROBiosystems is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and services. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China.
Through the continuous development of new technologies and products, ACROBiosystems creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.
Almac
Bronze Sponsor
Almac delivers services from development to commercial scale of advanced intermediates & Active Pharmaceutical Ingredients (API) for small molecules (including highly potent) and peptides. We have a proven track record of saving time & costs through the integration of our services & application of innovative biocatalysis & technology solutions. Supported by our radiolabelling, physical sciences and global analytical services teams, think Almac for drug development outsourcing solutions.
Asymchem Laboratories
Bronze Sponsor
Asymchem (Stock Code: 002821.SZ/6821.HK), a global CDMO leader, has provided one-stop pharmaceutical solutions for over 25 years. With a strong foundation in small molecule services, it has advanced capabilities in chemical macromolecules, biologics, drug products, clinical research, synthetic biology, and technology transfer. Supported by 9,000+ professionals—45% in R&D—and facilities in China, the U.S., the U.K., and beyond, Asymchem adheres to top-tier cGMP and EHS standards. Trusted by global pharma and biotech leaders, Asymchem delivers high-quality, cost-effective services, reducing time-to-market for therapies and providing client-centric solutions to meet the diverse needs of global drug development.
Atem
Bronze Sponsor
ATEM Structural Discovery is an innovation leader in next generation cryo-EM, delivering software enabled analytics and 3D structure determination. Founded by an interdisciplinary team and grounded in rigorous science, we operate at the forefront of Tech Bio to advance high throughput, AI enabled analytical applications for novel modalities and structure determination.
Bachem
Bronze Sponsor
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.
Beckman Coulter
Bronze Sponsor
At Beckman Coulter Life Sciences, we are partners in time. We accelerate answers to critical questions through the power of efficiency, saving hours from some workflows and delivering reliable outcomes in liquid handling, genomics, flow cytometry, particle analysis/counting, and centrifugation.
Our answer-accelerating technologies--from automated liquid handling systems and high-performance centrifuges to sophisticated flow cytometers, advanced cell counters, and bioanalyzers—help you achieve more efficient, accurate, and scalable cell culture processes, increasing the potential for higher quality and greater yields.
Carterra
Bronze Sponsor
Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra's high throughput LSA, LSA-XT, and Ultra platforms for monoclonal antibody (mAb) and small molecule screening and characterization combine patented microfluidics technology with real-time High-Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading analysis and visualization software. These systems deliver up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing label-free platforms.
Partnering with industry leaders, Carterra is at the forefront of developing high-throughput biological tools that advance artificial intelligence (AI), machine learning (ML), synthetic biology, and in silico discovery workflows.
By enabling rapid and comprehensive screening early in the discovery process, Carterra empowers researchers to identify unique epitopes and novel therapeutic candidates more efficiently enhancing innovation, accelerating timelines, and expanding intellectual property coverage.
CEM Corporation
Bronze Sponsor
Committed to the continuous advancement of solid-phase peptide synthesis, our goal is to develop the most effective and efficient SPPS workflow solutions for the peptide and peptidomimetic community.
Our performance- and efficiency-driven peptide synthesizer lines are available in both sequential and parallel formats, spanning research through production scale synthesis. We offer a suite of high-quality SPPS chemicals, including preloaded resins and amino acids in both bulk and conveniently pre-weighed options.
Our powerful purification system streamlines peptide isolation, simplifying the transition from analytical to preparative scale.
From reagent preparation and peptide synthesis to cleavage and purification, our dedicated team of scientists and engineers strive to simplify science, start to finish.
EuroAPI
Bronze Sponsor
Euroapi is a European leader in small molecule active pharmaceutical ingredients, with a unique industrial footprint and proven reliability.
We provide pharmaceutical and biotechnology companies with a wide range of active ingredients in many therapeutic areas. We benefit from large dedicated platforms and state-of-the-art equipment to produce our molecules, which are used to manufacture innovative and generic medicines.
• ~200 API in Portfolio
• HQ in Paris, France
• 5 manufacturing Sites
• 3000+ employes
• Sales and support teams covering 80+ countries
We work closely with our customers to co-develop innovative products through our Contract and Development Manufacturing Organization (CDMO) business.
• Strong adaptability and customization to better meet customer needs from early development through commercial release.
• 6 leading development and manufacturing sites located in Europe.
• Manufacturing excellence ensuring the highest levels of quality and regulatory compliance.
evitria
Bronze Sponsor
evitria is an established, global antibody expression service provider located in Zurich, Switzerland. We are specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies) and other proteins.
With a track record of more than 140,000 transfections performed and more than 25,000 antibodies / antibody based molecules expressed and purified for our clients from the Americas, Europe, Asia and Australia – ranging from academic laboratories and small biotech start-ups to global biopharmaceutical companies – you can benefit from our expertise when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
FluidAir Inc. Division of Spraying Systems Co.
Bronze Sponsor
Established in 1983, Fluid Air serves companies that manufacture powdered products and ingredients, in industries including biopharmaceutical, advanced batteries, nutraceutical, food, fine chemicals, and agriculture. Our PolarDry® electrostatic drying system allows customers to bypass the inherent constraints of freeze drying and conventional spray drying, achieving scalable production and lower costs. Learn more about Fluid Air at www.fluidairinc.com.
GemPharmatech
Bronze Sponsor
GemPharmatech is a global contract research organization that provides genetically engineered mouse models and preclinical research services to the scientific community. We have an extensive library of over 25,000 models including KO/cKO mice, humanized mice, immunodeficient mice, and germ-free mice, and continually expand our library to assist our customers in achieving their research goals. To further support our customers, we also offer custom model generation, breeding, and compound efficacy testing in our offices across China and the United States.
Gene Frontier
Bronze Sponsor
GeneFrontier offers a revolutionary cell-free protein expression platform, PUREfrex®. This highly customizable system enables precise control at the molecular level, making it ideal for producing a wide range of proteins including difficult-to-express proteins as well as for high-throughput screening of therapeutic biologics. By seamlessly integrating with AI/ML, PUREfrex® accelerates protein engineering and optimization, driving innovation in the biologics field.
Genovis
Bronze Sponsor
Genovis provides innovative tools that streamline analytical workflows in the biopharmaceutical and research industries, helping scientists save time in the development of new therapeutics and diagnostics. Our enzyme products, known as SmartEnzymes™, are a unique selection of rapid, easy-to-use enzymatic tools designed to enhance efficiency and throughput in both analytical and preparative workflows for complex biopharmaceuticals. Scientists worldwide rely on these enzymes for high-resolution protein analysis, from detailed structural characterization to biopharmaceutical development. With innovative product formats optimized for characterization, development, production, and quality control, Genovis simplifies even the most challenging analytical workflows.
Lunaphore Technologies SA, a Bio-Techne company
Bronze Sponsor
Bio-Techne’s leading spatial biology brands, Advanced Cell Diagnostics and Lunaphore, are transforming the future of research and precision medicine. From low-plex chromogenic to high-plex fluorescent assays, the scalable platforms and fully automated same-section multiomics workflows bring unmatched performance and flexibility to scientists. Powered by the gold-standard RNAscope™ technology and Lunaphore’s flagship end-to-end fully-automated COMET™ product suite, Bio-Techne equip researchers with the right tools to drive breakthroughs and accelerate the journey from discovery to clinic.
Rapid Novor
Bronze Sponsor
Rapid Novor helps researchers decode immunity so they can rapidly and effortlessly develop diagnostics, therapies and reagents. Services include:
- Antibody Discovery
- Antibody Sequencing
- Epitope Mapping
- SPR
- Antibody Characterization
The innovative next generation protein sequencing technology we’ve developed has unlocked countless discoveries for human health.
Refeyn
Bronze Sponsor
Refeyn pioneers analytical instruments that put molecular mass measurement capabilities within easy reach for scientists. Refeyn’s products feature mass photometry – which uses light to weigh individual proteins, nucleic acids, complexes and viruses. Returning intuitive data in minutes, mass photometry provides vital insights for scientific discovery, R&D and therapeutics production.
Refeyn’s mission is to transform analytical workflows in the life sciences, biopharma and beyond, using the power of light.
WuXi Biologics
Bronze Sponsor
WuXi Biologics is a leading global CRDMO, with the R represented by our premium-quality CRO Services. With expertise in diverse drug modalities, we deliver comprehensive research services, including antibody discovery, protein production and engineering, and in vitro/in vivo testing, to seamlessly advance our clients’ molecules from concept to CMC development.
Zhejiang Jiuzhou Pharmaceutical Co.
Bronze Sponsor
Jiuzhou Pharma is a global Contract Development and Manufacturing Organization (CDMO) focused on the development and manufacturing of small molecule and peptide APIs (active pharmaceutical ingredients) and finished dose drug products. With subsidiaries in China, North America, Europe, Singapore, and Japan, and a company history over 50 years, Jiuzhou Pharma provides full-lifecycle contract development and manufacturing services from fully compliant cGMP laboratories to research institutions and biotech and pharmaceutical companies worldwide and has globally launched 38 innovative drugs.
One-stop CDMO services support preclinical, clinical, and commercial production for small molecules, peptides, and drug conjugates. With an EcoVadis Gold rating, Jiuzhou Pharma continues to push the boundaries of sustainable pharmaceutical manufacturing. A commitment to continuous innovation in green chemistry, lifecycle impact reduction, and responsible global manufacturing ensures that we remain a trusted, forward-thinking CDMO partner for the future of pharmaceuticals.
Network & Programme Sponsors
Abselion
Network & Programme Sponsor
Abselion develops practical measurement tools that simplify complex biological workflows and deliver reliable, actionable data.
We create solutions that bring together robust engineering, purpose-built assay formats, and intuitive software. Our approach enables faster, more confident decisions in life sciences, biotechnology, and therapeutic development without the cost or complexity of traditional systems.
Founded as a spin-out from the University of Cambridge, Abselion was created to make scientific measurement both precise and practical. We continue to expand our capabilities to meet evolving research needs, delivering tools that are dependable, easy to use, and built for the pace of today’s research.
Aptamer Group
Network & Programme Sponsor
Aptamer Group is a leading developer of next-generation synthetic binders for the life sciences industry. The Group develops Optimer® binders, advanced molecules that act like antibodies by binding to specific targets. These binders are used in medicine, diagnostic tests, and research tools, offering benefits such as high stability, reliable performance, and lower costs compared with traditional antibodies.
AVS Bio (ImmunoPrecise Antibodies)
Network & Programme Sponsor
AVS Bio is a leading provider of antibody discovery and development services, dedicated to delivering next-generation therapeutic and diagnostic antibodies with greater efficiency, shorter timelines, and potentially higher (clinical) performance. Our expertise spans a wide spectrum of targets, including complex and challenging antigens, supported by advanced platforms such as hybridoma generation, B cell screening, phage display technologies, scalable protein production, and high throughput antibody humanization/optimization and triaging workflows.
To further accelerate our clients’ success, we offer a broad suite of supporting services including immunoassays, in vitro functional characterization, stable cell line development, and large batch production of recombinant proteins.
AVS Bio partners with pharmaceutical, biotechnology, and research organizations worldwide to advance innovative biologics development and impactful solutions for patients.
Bioassay - a Reaction Biology Company
Network & Programme Sponsor
Bioassay GmbH – a Reaction Biology Company is a premier bioanalytical contract research organization specializing in the development, validation and routine performance of bioassays under GMP and GLP standards. Our expert team delivers tailored potency, efficacy and safety testing for biologics, vaccines, monoclonal antibodies, hormones and other complex therapeutics to support regulatory approval and reliable batch release. As part of the global Reaction Biology group, we combine world-class scientific expertise with rigorous quality systems to advance pharmaceutical, biotechnology, chemical and veterinary products. Based in Heidelberg, Germany, we help clients worldwide bring safe, effective products to market.
BIOVIA
Network & Programme Sponsor
BIOVIA drives AI-powered scientific breakthroughs by bringing Generative AI to Every Scientist — accelerating products to market. As the only cloud platform that unites physics-based modeling, scientific AI, lab data, and quality management, we provide the comprehensive digital backbone that spans from Molecule to Manufacturing.
.jpg?length=600&name=61ac7f24-46f1-4373-9564-8293c215c0a7-2-5668375logo-CDDV_L_BLUE_ON_WHITE_CMYK-(9).jpg)
Collaborative Drug Discovery (CDD)
Presentation & Exhibition
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by innovative biologists and chemists across academic, biotechnology, and pharmaceutical organizations. Its flagship platform, CDD Vault, enables researchers to securely manage and analyze both chemical and biological data through a user-friendly web interface. The platform supports entity registration, including small molecules, biologics, and complex modalities like ADCs, while offering robust inventory tracking, bioassay data management, SAR analysis, and experiment capture via its integrated Electronic Laboratory Notebook (ELN). CDD Vault also includes AI-powered tools for data mining and drug candidate prioritization, helping teams extract actionable insights more efficiently. Known for its intuitive design, strong performance, and secure collaboration workflows, CDD Vault facilitates seamless data sharing across internal teams and external partners. Founded in 2004, CDD today serves thousands of researchers worldwide, accelerating preclinical discovery and early-stage R&D efforts.
Learn more at www.collaborativedrug.com
Crown Bioscience
Network & Programme Sponsor
Crown Bioscience is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support.
With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications.
Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities.
Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO).
Eurogentec
Network & Programme Sponsor
Eurogentec is an international company founded in 1985 and part of Kaneka Corp. since 2010.
Eurogentec is recognized as one of the major suppliers in the field of genomics (Oligonucleotides, qPCR kits & reagents) and proteomics (Custom & catalog antibodies and peptides) as well as a trusted Contract Development and Manufacturing Organization (CDMO) for the production process development and manufacturing of vaccines and medicines (therapeutic oligonucleotides, GMP Peptides, GMP plasmids, GMP recombinant proteins, mRNA…).
Eurogentec provides products and services to scientists involved in the life science research, molecular diagnostics and therapeutic development.
HistologiX
Network & Programme Sponsor
HistologiX is a trusted GLP & GCP compliant CRO for tissue-based biomarker analysis - make the most of our expertise. We help you visualise and understand what your drug or device is doing to your key biomarkers at the cellular and tissue level. Working collaboratively, our experienced scientific team provides a bespoke service allowing you to make the most of our expertise in histology, immunohistochemistry (IHC) including multiplex immunofluorescence (IF), In Situ Hybridisation (ISH) using RNAScope & cutting-edge digital image analysis using Visiopharm. For each project, our experienced scientists work as an extension of your in-house team to define your bespoke project requirements and customise the study plan to ensure you get the results you need. We provide an excellent quality technical service supporting biomarker evaluation of cutting-edge therapeutics including cell and gene therapies, oncolytic viruses, therapeutic antibodies, small molecules, and RNA modifying enzymes.
Hooke Bio
Network & Programme Sponsor
Hooke Bio Ltd is an innovative biotechnology company based in Shannon, Ireland, focused on advancing early-stage drug discovery and preclinical research through cutting-edge microfluidic and 3D microtissue screening technologies.
Its patent-protected Mera system is an automated, modular Microphysiological System (MPS) platform that integrates scalable fluidic control, precise environmental regulation, and non-invasive real-time imaging within a single streamlined workflow. Designed to operate under physiologically relevant flow conditions, Mera replicates dynamic perfusion and mechanical cues found in vivo, enabling multi-tissue arrays and powerful “Body-on-a-Plate” assays that capture critical inter-organ interactions beyond the capability of static cultures.
The result is more predictive, human-relevant data with real-time monitoring of drug efficacy and toxicity, accelerating development timelines while reducing cost and risk across the drug discovery pipeline.
Icosagen
Network & Programme Sponsor
Icosagen is a private, independent family-business, advancing therapeutic proteins from mammalian cells since 26 years.
As CRDMO, we uniquely combine pre-clinical CRO & clinical CDMO capabilities at one site, advancing molecules from discovery through R&D stages, into stable IcoCell® CHO cell lines & GMP manufacturing. From mAbs, complex multi-specifics to ADCs or recombinant proteins, We accelerate the programs of over 100 biotechs annually, eliminating error-prone tech transfers to save our partners’ time, cost & effort.
Our team welcomes open scientific dialogue at any stage. Whether you have early ideas, complex challenges, or simply questions about integrated biologics development. Let’s connect during the conference.
Ingenza
Network & Programme Sponsor
The Protein CRDMO advancing biologics drug substance development. We integrate AI/ML-empowered design, strain and cell-line engineering, process development and scalable manufacturing to deliver robust, predictable performance. With multi-host expression systems, high-end analytics and data-driven fermentations, we enable efficient, scalable process development across a broad range of protein-based modalities.
Janvier Group (MImAbs | RD-Biotech | Firalis MP | JLabs)
Network & Programme Sponsor
Since 1960, the Janvier Group has established itself as a global player in biosciences, supporting thousands of international clients in their search for innovative therapies. The group offers an integrated range covering the entire research continuum, from compound discovery to clinical phases, as well as comprehensive bioproduction services and a panel of in vivo and organoid models. As the last European family-owned group in the sector, Janvier Group Biosciences derives from its independence and long-term vision the ability to make quality and confidentiality its absolute priorities. At every stage, its teams of experts provide dedicated scientific support, transforming the most complex research questions into actionable data that advance therapeutic innovation.
Leukocare AG
Network & Programme Sponsor
Leukocare – Advancing Biologic Drug Product Development
Leukocare is a science-driven formulation development partner specialized in biologics, including monoclonal antibodies, viral vectors, vaccines, and other complex biologics. We support biotech and pharmaceutical companies from early development through life-cycle management of marketed products
Our approach combines deep formulation expertise, advanced bioinformatic and biostatistic approaches for data-driven decision making to systematically address stability, and delivery challenges. Rather than applying standard platform formulations, we tailor strategies to the specific molecular and program needs of each project.
Leukocare’s unique technologies integrate experimental data with computational tools to better understand degradation mechanisms, excipient in the desired route of administration, and formulation risks early on. This enables faster, more informed development decisions, reduces trial-and-error, and supports efficient progression toward clinical and commercial milestones.
We work as an extension of our clients’ CMC teams, valuing close collaboration, scientific transparency, and flexibility.
Headquartered in Germany, Leukocare operates with 50 people and a strong international footprint and a track record of successfully advancing challenging biologic drug products toward the clinic.
Leukocare – Smart formulation for better biologics.
.jpeg?length=600&name=82caff72-ab1d-41bf-aa58-38a89a3b5d74-2-5668375logo-NOVILYTIC-Logo-FINISH-ValerieP23Jun2020v1_-For-Mira-Awards-(002).jpeg){kind=logo}
Novilytic
Network & Programme Sponsor
Novilytic provides simpler, cleaner, protein-quality insights that streamline analysis and enable labs to do more with less.
Inspired by the saying “canary in the coal mine,” Novilytic is “The Canary in the Fermentor,” delivering near-real-time protein quality insights that help upstream scientists detect issues early and move quickly to the next sample.
-(1)-(1)-58ca14.png?length=600&name=81995b69-e5b1-45ad-a889-8693e6151276-2-5668375logo-Nuclera_Logo_Principal_Blue-(3)-(1)-(1)-58ca14.png){kind=logo}
Nuclera
Network & Programme Sponsor
Nuclera’s mission is to accelerate discovery by providing researchers rapid, easy access to the highest-quality functional proteins essential for drug discovery research. The Company’s eProtein Discovery™ benchtop system combines unique cell-free expression systems, novel digital microfluidics, and robust screening data to empower scientists to perform multiplex protein screening, characterization, and small-scale expression in-house.[BR1]
By providing clear guidance on which protein has the best chance of success from the start, eProtein Discovery™ reduces the time, cost, and uncertainty traditionally associated with protein expression and purification. Researchers can generate soluble, purified proteins, including challenging membrane proteins[BR2] , for downstream functional testing in under 48 hours, significantly accelerating workflows compared with months-long cell-based methods.
Founded in 2013, Nuclera has offices in Cambridge (UK) and Boston (US).
For more information, please visit www.nuclera.com
Octapharma
Network & Programme Sponsor
Octapharma are the world’s largest privately owned plasma fractionator, with over 40 years of experience in the industry. Octapharma produce a range of GMP grade plasma derived proteins and serum media additives for the Life Sciences sector. Suitable for Cell & Gene Therapy, Vaccine Development, RNA/DNA Therapeutics, In Vitro Diagnostics, Immunoassays, and wider CDMO/CRO/CMO usage. All proteins are GMP grade, produced to a medicinal standard, and double-pathogen reduced. Bespoke and tailored regulatory documents can also be supplied to support approval body submission where material is listed as an excipient. With several concentrations available for each product, we can confidently support small-scale laboratory use, right through to end product manufacture, supporting all paces of company scale-up.
Phenomenex
Network & Programme Sponsor
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government, and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.
Propath UK
Network & Programme Sponsor
Propath UK are a specialist CRO with expertise in spatial biology, molecular pathology, image analysis and histopathology. For four decades we have successfully collaborated on studies with biopharma and are recognised as a leading specialist providing genuine expertise to our clients.
From our GCP/GLP compliant facility we provide:
• Spatial transcriptomics/proteomics (CosMx™, GeoMx®)
• Multiplex immunofluorescence (COMET™, PhenoCycler®Fusion, PhenoImager® HT)
• Targeted bulk gene expression (nCounter)
• Image analysis (Visiopharm®, R)
• Molecular pathology
• Histology
Whilst adhering to deadlines is a given, our approach is to first invest time with our clients to understand their scientific objectives and then provide tailored solutions to achieve them.
Ribbon Biolabs
Network & Programme Sponsor
Ribbon Bio is a synthetic biology leader driving DNA synthesis beyond the limits of current technologies: making the impossible possible. We are redefining scientific possibility with our algorithm-driven technology that produces pristine synthetic DNA molecules, at a high level of accuracy and scale, enabling our partners to deliver a new generation of transformative solutions for the health of people and the planet. For more information, visit us at www.ribbonbio.com.
SGS
Network & Programme Sponsor
With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers, and finished products.
SGS provides a comprehensive range of biosafety services such as: virology, cell and molecular biology, microbiology, and TEM. Health Authorities (US FDA and the EMA), require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses, and other potential contaminants. SGS ensures product safety in satisfying these regulatory requirements.
Sino Biological
Network & Programme Sponsor
Sino Biological is a global life sciences company specialising in high-quality recombinant proteins, antibodies, and custom CRO services to support drug discovery, translational research, and therapeutic development. With an extensive catalogue covering cytokines, growth factors, receptors, viral proteins, and engineered antibodies, Sino Biological enables scientists worldwide to accelerate biologics research.
In addition to off-the-shelf reagents, Sino Biological offers flexible custom solutions including protein expression and purification, antibody development, plasmid construction, and complex biologic formats such as bispecific antibodies. By combining broad catalogue capabilities with tailored project support, Sino Biological partners with biotech, pharma, and academic institutions to advance next-generation therapeutics.
The Jackson Laboratory
Network & Programme Sponsor
The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institution with a National Cancer Institute-designated Cancer Center. JAX leverages a unique combination of research, education, and resources to achieve its bold mission: to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health. Established in Bar Harbor, Maine in 1929, JAX is a global organization with nearly 3,000 employees worldwide and campuses and facilities in Maine, Connecticut, California, Florida, and Japan.
Start-Ups
Avigen
Start Up Zone
Avigen is a preclinical Contract Research Organisation advancing the discovery and validation of next-generation cell-based immunotherapies and biologics.
Across cell therapies and immune cell engagers, Avigen’s proprietary platform addresses a critical gap in preclinical evaluation: accurately measuring the quality of immune–target engagement. By quantifying cellular avidity, the total functional binding strength between living immune and target cells under controlled fluidic force, we provide a more physiologically relevant readout than conventional legacy functional assays.
Our high-throughput, target-specific technology enables parallel testing, stratification, and isolation of effector cells based on functional binding strength and activation behaviour. This allows biotech and pharmaceutical teams to identify superior constructs earlier, de-risk go/no-go decisions, and improve alignment between in-vitro findings and in-vivo performance.
Working across all modalities including CAR-T, TCR-T, NK, CAR-NK, CAR-iNKT, TIL, and cell engager programmes, Avigen supports streamlined development and confident therapeutic translation, reducing cost, time, and uncertainty in preclinical pipelines.
ImmuneWatch
Start Up Zone
ImmuneWatch is a computational immunology company with a core mission to solve the T cell specificity problem with machine learning. We are a university spin-off founded in 2021 and headquartered in Antwerp, Belgium. Our solutions support the design, development, and clinical translation of vaccines and immunotherapies for which T cell responses play a crucial role.
The T cell receptor (TCR) repertoire holds huge amounts of information on past, present and future immune responses of an individual. Decoding this information is crucial for understanding T cell responses in the context of cancer, infectious diseases and autoimmune diseases. ImmuneWatch’s extensive database and software can identify TCRs of clinical relevance and annotate the epitope specificity of TCR sequences, turning TCR repertoires into clinically actionable data. Our DETECT translational immunology solution is proven to be the best-in-class machine learning algorithm in a public benchmarking competition, fueled by the largest curated TCR-epitope database to date (IMWdb). DETECT is applicable on output from all bulk or single cell TCR sequencing technologies, and available as service or software for in-house use. Our areas of expertise and core applications are immune monitoring of T cell responses following vaccination or immunotherapy, TCR biomarker identification, T cell product characterisation, discovery of immunogenic antigens and epitopes (target deconvolution), and patient stratification. Across these applications, we work with biopharma and academic researchers around the world to provide tailored, data-driven insights in clinical immune responses.
Photene
Start Up Zone
Photene is a structural biology service which uses its Carbene Footprinting technology to map protein binding sites, interactions and conformational changes. We use a bottom up proteomic workflow coupled to high resolution mass spectrometry analysis to produce data with spatial resolution down to individual amino acids. The technique employs a diazirine containing probe which upon irradiation with near-UV light generates a highly reactive carbene species. The carbene inserts into the accessible sites of the protein surface, creating covalent labels that capture a precise snapshot of any binding events and structural dynamics under native-like conditions.
Photene’s Carbene Footprinting platform can be applied to a wide variety of biomolecular systems, including protein-protein, protein-peptide, protein-small molecule and antibody-antigen binding interactions. Combining rapid photochemical labelling with advanced high resolution mass spectrometry workflows, Photene delivers powerful structural information for your products.
Vixen Bio
Start Up Zone
At Vixen Bio, we empower the world of biologics by providing physiological and clinically-relevant data earlier in the drug and Biomarker development process.
We derisk development and clinical trials early by fast, custom measurements in clinically relevant conditions. With deep expertise in immunology and advanced analytics, we specialize in:
1) affinity ranking of biologics, auto antibodies and ADA in clinically- and diagnostic-relevant environments like serum, plasma or whole blood;
2) live monitoring of complement recruitment; and
3) rapid effector function testing (ADCC/ADCP) that bypasses the long culture of target cells.
We therefore support faster, more informed, and safer drug and diagnostic development. Our mission is to help CROs, pharma and biotech companies accelerate innovation - from discovery through clinical trials - by delivering precise, immune response-driven insights that inform better design, production, dosing, earlier detection of adverse effects, and more personalized treatment strategies. We’re not just a service provider, we’re a partner in innovation. Whether it's navigating complex biologics design or optimizing clinical trial outcomes, Vixen Bio is committed to making precision medicine a reality.
